{"name":"Anita Syla Lokaj","slug":"anita-syla-lokaj","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Autologous serum","genericName":"Autologous serum","slug":"autologous-serum","indication":"Severe dry eye syndrome/keratoconjunctivitis sicca","status":"marketed"}]}],"pipeline":[{"name":"Autologous serum","genericName":"Autologous serum","slug":"autologous-serum","phase":"marketed","mechanism":"Autologous serum is a patient's own blood serum used topically to provide growth factors and immunomodulatory components that promote tissue healing and reduce inflammation.","indications":["Severe dry eye syndrome/keratoconjunctivitis sicca","Ocular surface disease refractory to conventional therapy","Stevens-Johnson syndrome ocular complications","Graft-versus-host disease (ocular manifestations)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPbFZYUXNOZVJEcFJ3MU9aZmNmQ1BjVnJRSUdBcEhobjJsTG9mSHdpTFlyaVppOWp5TUdkM0UwQ2dPRVJZQ1pDWWxmcWRHU2JlLWsxVHdleDdyak4tdktuWk1BSmdtZ2I3RGR4ZzVHNTd2QXd0YkNBWXpGMDlTWHpyZmVaam1vNERRV0NkdlQ2OWxacVRPeVJZRnI4Z1ptSFR1S3FvcjY3cklUblA4SUdaS2Z3?oc=5","date":"2021-12-23","type":"pipeline","source":"Healio","summary":"SMILE treats residual refractive error after cataract surgery - Healio","headline":"SMILE treats residual refractive error after cataract surgery","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}